8002:TSEMarubeni Corporation Analysis
Data as of 2026-05-25 - not real-time
¥5,312.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Marubeni Corp (8002.T) trades around ¥5,312, comfortably above its recent support of ¥5,216 but well below its 52‑week high of ¥6,328. The stock’s price‑to‑earnings multiple sits at roughly 16×, notably lower than the conglomerate industry average of about 30×, indicating a relative valuation advantage. However, a discounted cash‑flow model pins a fair value near ¥809, suggesting the market may be pricing in significant risk premiums. The company delivers a solid dividend yield of 2.18% backed by a modest payout ratio of 32%, and its cash flow generation comfortably covers dividend obligations. With a debt‑to‑equity ratio of 53% and a healthy ROE of 13.5%, the balance sheet is manageable, especially given the ample cash reserves exceeding ¥550 bn.
On the technical side, the 14‑day RSI of 38 points to mild oversold conditions, while the MACD histogram remains negative, signalling short‑term bearish momentum. Volume trends are decreasing, and the 20‑day SMA (¥5,670) lies above the current price, reinforcing a neutral to slightly bearish near‑term outlook. The stock’s beta of 0.38 and a 30‑day volatility of roughly 37% reflect low systematic risk but elevated price swings, typical for a diversified Japanese conglomerate. The “Extreme Greed” sentiment on the fear‑greed index hints at heightened market optimism that could compress valuations further. Considering these factors, the valuation leans toward being overvalued relative to intrinsic DCF estimates, yet the fundamentals and dividend profile remain attractive for value‑oriented investors. Consequently, we rate the stock as overvalued but value‑blend in style, with a sustainable dividend. Risk assessment places overall risk at a modest 4/10, with sector and regulatory risks rated medium, geographic and currency risks medium, and liquidity risk low. Our short‑term view is to hold, reflecting the bearish MACD and decreasing volume, while the medium‑term outlook upgrades to buy given the upside potential of ~19% and solid fundamentals. Over the long horizon we maintain a buy stance, banking on diversified earnings, stable cash flow, and the ability to navigate commodity cycles.
On the technical side, the 14‑day RSI of 38 points to mild oversold conditions, while the MACD histogram remains negative, signalling short‑term bearish momentum. Volume trends are decreasing, and the 20‑day SMA (¥5,670) lies above the current price, reinforcing a neutral to slightly bearish near‑term outlook. The stock’s beta of 0.38 and a 30‑day volatility of roughly 37% reflect low systematic risk but elevated price swings, typical for a diversified Japanese conglomerate. The “Extreme Greed” sentiment on the fear‑greed index hints at heightened market optimism that could compress valuations further. Considering these factors, the valuation leans toward being overvalued relative to intrinsic DCF estimates, yet the fundamentals and dividend profile remain attractive for value‑oriented investors. Consequently, we rate the stock as overvalued but value‑blend in style, with a sustainable dividend. Risk assessment places overall risk at a modest 4/10, with sector and regulatory risks rated medium, geographic and currency risks medium, and liquidity risk low. Our short‑term view is to hold, reflecting the bearish MACD and decreasing volume, while the medium‑term outlook upgrades to buy given the upside potential of ~19% and solid fundamentals. Over the long horizon we maintain a buy stance, banking on diversified earnings, stable cash flow, and the ability to navigate commodity cycles.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD
- Decreasing volume
- Price near support
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF upside potential
- Attractive dividend yield
- Low beta
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Diversified business model
- Strong cash generation
- Stable dividend policy
Key Metrics & Analysis
Financial Health
Revenue Growth1.10%
Profit Margin6.58%
P/E Ratio16.1
ROE13.50%
ROA1.63%
Debt/Equity53.39
P/B Ratio2.0
Op. Cash Flow¥535.4B
Free Cash Flow¥233.3B
Industry P/E29.7
Technical Analysis
TrendNeutral
RSI38.3
Support¥5,216.00
Resistance¥6,160.00
MA 20¥5,670.60
MA 50¥5,726.80
MA 200¥4,584.05
MACDBearish
VolumeDecreasing
Fear & Greed Index91.77
Valuation
Fair Value¥809.15
Target Price¥6,331.54
Upside/Downside19.19%
GradeOvervalued
TypeValue
Dividend Yield2.18%
Risk Assessment
Beta0.38
Volatility36.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.